Comparison of Vendor-Independent Software Tools for Liver Proton Density Fat Fraction Estimation at 1.5 T

(1) Background: Open-source software tools are available to estimate proton density fat fraction (PDFF). (2) Methods: We compared four algorithms: complex-based with graph cut (GC), magnitude-based (MAG), magnitude-only estimation with Rician noise modeling (MAG-R), and multi-scale quadratic pseudo-...

Full description

Bibliographic Details
Published in:	Diagnostics
Main Authors:	Zita Zsombor, Boglárka Zsély, Aladár D. Rónaszéki, Róbert Stollmayer, Bettina K. Budai, Lőrinc Palotás, Viktor Bérczi, Ildikó Kalina, Pál Maurovich Horvat, Pál Novák Kaposi
Format:	Article
Language:	English
Published:	MDPI AG 2024-05-01
Subjects:	chemical-shift-encoded MRI (CSE-MRI) proton density fat fraction (PDFF) open-source software phantom quantitative imaging biomarker metabolic-associated steatotic liver disease (MASLD)
Online Access:	https://www.mdpi.com/2075-4418/14/11/1138

Similar Items

Automated shape-independent assessment of the spatial distribution of proton density fat fraction in vertebral bone marrow
by: Tobias Haueise, et al.
Published: (2024-08-01)

Quantitative Ultrasound for Hepatic Steatosis: A Systematic Review Highlighting the Diagnostic Performance of Ultrasound-Derived Fat Fraction
by: Dimitrios Kavvadas, et al.
Published: (2025-10-01)

Construction of a Compound Model to Enhance the Accuracy of Hepatic Fat Fraction Estimation with Quantitative Ultrasound
by: Zsély Boglárka, et al.
Published: (2025-01-01)

Consecutive fecal microbiota transplantation for metabolic dysfunction-associated steatotic liver disease: a randomized controlled trial
by: Bas Groenewegen, et al.
Published: (2025-12-01)

Focal Liver Lesion MRI Feature Identification Using Efficientnet and MONAI: A Feasibility Study
by: Róbert Stollmayer, et al.
Published: (2022-05-01)

Comparative Efficacy of NAFLD Therapies and Biomarker Associations: A Meta-Analysis Based on Liver Fat Content
by: Haoxiang Zhu, et al.
Published: (2025-01-01)

Quantification of liver fat using non-invasive MRI-PDFF technique versus guided biopsy in potential liver donor
by: Hany El-Assaly, et al.
Published: (2024-08-01)

Improved Ultrasound Evaluation Method for Diagnosing Nonalcoholic Fatty Pancreatic Disease: Correlation with MRI mDixon-Quant
by: Lin Jiaojiao, Ke Helin, Xu Shaodan, Xiao Yang, Han Lina, Lyu Guorong, Li Shilin
Published: (2025-06-01)

Triglyceride Saturation in Patients at Risk of NASH and NAFLD: A Cross-Sectional Study
by: Mark Bydder, et al.
Published: (2021-12-01)

Radiomics analysis of contrast-enhanced CT scans can distinguish between clear cell and non-clear cell renal cell carcinoma in different imaging protocols
by: Bettina Katalin Budai, et al.
Published: (2022-10-01)

Evaluation of Artificial Intelligence-Calculated Hepatorenal Index for Diagnosing Mild and Moderate Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease
by: Zita Zsombor, et al.
Published: (2023-02-01)

Diagnostic Performance of Ultrasound in Detecting Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease Considering MRI Proton Density Fat Fraction as the Reference Standard
by: Ankita Aggarwal, et al.
Published: (2024-01-01)

The Calculation and Evaluation of an Ultrasound-Estimated Fat Fraction in Non-Alcoholic Fatty Liver Disease and Metabolic-Associated Fatty Liver Disease
by: Pál Novák Kaposi, et al.
Published: (2023-10-01)

Bariatric intervention improves metabolic dysfunction-associated steatohepatitis in patients with obesity: A systematic review and meta-analysis
by: Juchul Hwang, et al.
Published: (2024-07-01)

Outlier data in volume calculations of uterine fibroids comparing ellipsoid formula and voxel-based segmentation
by: Viktor Bérczi, et al.
Published: (2025-05-01)

Assessing Quality of Ultrasound Attenuation Coefficient Results for Liver Fat Quantification
by: Giovanna Ferraioli, et al.
Published: (2024-09-01)

Microvascular flow imaging to differentiate focal hepatic lesions: the spoke-wheel pattern as a specific sign of focal nodular hyperplasia
by: Aladár David Rónaszéki, et al.
Published: (2023-01-01)

Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study
by: Aruhan Yang, et al.
Published: (2024-10-01)

The Impact of an SGLT2 Inhibitor versus Ursodeoxycholic Acid on Liver Steatosis in Diabetic Patients
by: Sahar H. Elhini, et al.
Published: (2022-12-01)

The diagnostic value of MRI-PDFF in hepatic steatosis of patients with metabolic dysfunction-associated steatotic liver disease: a systematic review and meta-analysis
by: Yue-Xia Zhang, et al.
Published: (2025-07-01)

Methods and validation of velacur determined fat fraction in patients with MASLD
by: Mohammad Honarvar, et al.
Published: (2024-12-01)

Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional study
by: Di Cao, et al.
Published: (2022-05-01)

Evaluation of junctional zone differential and ratio as possible markers of clinical efficacy in uterine artery embolisation of adenomyosis
by: Kolos Turtóczki, et al.
Published: (2024-07-01)

Accuracy of attenuation coefficient measurement (ACM) for real-time ultrasound hepatic steatometry: Comparison of simulator/phantom data with magnetic resonance imaging proton density fat fraction (MRI-PDFF)
by: Nazarii Kobyliak, et al.
Published: (2023-10-01)

Electro-acupuncture reduced steatosis on MRI-PDFF in patients with non-alcoholic steatohepatitis: a randomized controlled pilot clinical trial
by: Jingjie Zhao, et al.
Published: (2023-02-01)

Different Ultrasound Shear Wave Elastography Techniques as Novel Imaging-Based Approaches for Quantitative Evaluation of Hepatic Steatosis—Preliminary Findings
by: Natascha Platz Batista da Silva, et al.
Published: (2023-03-01)

MRI-PDFF Assessment of Intrahepatic Fat Changes Post-Bariatric Surgery: A Systematic Literature Review
by: Danut Dejeu, et al.
Published: (2024-12-01)

A deep learning aided bone marrow segmentation of quantitative fat MRI for myelofibrosis patients
by: Humera Tariq, et al.
Published: (2025-05-01)

Designing a compact MRI motion phantom
by: Schmiedel Max, et al.
Published: (2016-09-01)

Applicability of Statins in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
by: Thaninee Prasoppokakorn
Published: (2025-01-01)

Leukocyte telomere shortening in metabolic dysfunction-associated steatotic liver disease and all-cause/cause-specific mortality
by: Donghee Kim, et al.
Published: (2024-10-01)

Políticas públicas na faixa de fronteira do Brasil: PDFF, CDIF e as políticas de segurança e defesa
by: Camilo Pereira Carneiro Filho, et al.
Published: (2019-09-01)

Steatotic liver disease in people with HIV at Tshepong Hospital: A post-mortem analysis
by: Aqeela Moosa, et al.
Published: (2024-12-01)

Detection accuracy of I-125 seeds and needle tips, in MRI prostate tissue mimicking material: Phantom design, fabrication, and testing
by: Sarah Wilby, et al.
Published: (2022-11-01)

Assessment of Reproducibility of Geometric Distortion in MRI using Phantom Measurements
by: M. Ashkanmehr, et al.
Published: (2005-09-01)

Cumulative Effect of Metabolic Factors on Hepatic Steatosis
by: Anna Egresi, et al.
Published: (2025-09-01)

Feasibility of Sodium and Amide Proton Transfer-Weighted Magnetic Resonance Imaging Methods in Mild Steatotic Liver Disease
by: Diana M. Lindquist, et al.
Published: (2025-08-01)

Evaluation of the ACR MRI phantom for quality assurance tests of 1.5 T MRI scanners in Estonian hospitals; pp. 328–334
by: Doris Kaljuste, et al.
Published: (2014-08-01)

The effect of quality control on the function of magnetic resonance imaging (MRI), using American College of Radiology (ACR) phantom
by: H.M. Etman, et al.
Published: (2017-03-01)

A prediction model of liver fat fraction and presence of non-alcoholic fatty liver disease (NAFLD) among patients with overweight or obesity
by: Jie Chen, et al.
Published: (2023-10-01)